New Treatment for Opioid-Induced Constipation
| dc.contributor.author | Aschenbrenner, Diane S. | |
| dc.contributor.department | Sandra R. Berman School of Nursing and Health Professions | en_US |
| dc.contributor.program | Nursing | en_US |
| dc.date.accessioned | 2017-09-27T20:20:30Z | |
| dc.date.available | 2017-09-27T20:20:30Z | |
| dc.date.issued | 2015-01 | |
| dc.description.abstract | The opioid antagonist naloxegol (Movantik) is now approved to treat opioid-induced constipation in adults with chronic noncancer pain. The most common adverse effects are abdominal pain, diarrhea, nausea, flatulence, vomiting, and headache. | en_US |
| dc.description.uri | https://ezproxy.stevenson.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=rzh&AN=107811913&site=eds-live&scope=site | en_US |
| dc.format.extent | 1 page | en_US |
| dc.genre | journal articles | en_US |
| dc.identifier | doi:10.13016/M2Q814S84 | |
| dc.identifier.citation | Aschenbrenner, D. S. (2015). New treatment for opioid-induced constipation. AJN American Journal of Nursing, 115(1), 23. doi:10.1097/01.NAJ.0000459622.00045.fd | en_US |
| dc.identifier.uri | http://dx.doi.org/10.1097/01.NAJ.0000459622.00045.fd | |
| dc.identifier.uri | http://hdl.handle.net/11603/5655 | |
| dc.language.iso | en_US | en_US |
| dc.publisher | American Journal of Nursing | en_US |
| dc.title | New Treatment for Opioid-Induced Constipation | en_US |
| dc.type | Text | en_US |
Files
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: